Sodium-glucose co-transporter 2 inhibitors on weight change and cardiometabolic profiles in individuals with overweight or obesity and without diabetes: A meta-analysis.

Obesity Reviews : an Official Journal of the International Association for the Study of Obesity
John WongKenneth Lo


Several meta-analyses have been conducted to evaluate the weight loss effect of sodium-glucose cotransporter 2 (SGLT-2) inhibitors in patients with type 2 diabetes, whereas pooled analysis focusing on individuals without diabetes is lacking. The objective of this systematic review and meta-analysis is to evaluate the effect of SGLT-2 inhibitor monotherapy on weight change and cardiometabolic profiles. Multiple databases were searched for randomized controlled trials reporting weight change effect of SGLT-2 inhibitor treatment compared with placebo for more than 12 weeks among individuals with overweight or obesity and without diabetes. A total of eight randomized controlled trials with 750 subjects were identified. SGLT-2 monotherapy was associated with significant reduction in body weight of -2.32 kg, compared to -1.01 kg for placebo, giving a mean difference of -1.31 kg. Significant reductions in body mass index and fasting blood glucose were observed, but not for the changes in waist circumference, fat mass, blood pressure, and lipid profile compared with placebo. SGLT-2 inhibitor monotherapy for 12 weeks or more can result in modest weight loss among people with overweight or obesity and without diabetes. Depending on pre-e...Continue Reading


Jul 1, 1992·Journal of Clinical Epidemiology·D FollmannJ Cutler
Jul 6, 2005·International Journal of Obesity : Journal of the International Association for the Study of Obesity·J D DouketisD F Williamson
Oct 4, 2005·Lancet·David W Haslam, W Philip T James
Jul 26, 2011·BMJ : British Medical Journal·Jonathan A C SterneJulian P T Higgins
Oct 20, 2011·BMJ : British Medical Journal·Julian P T HigginsUNKNOWN Cochrane Statistical Methods Group
Jan 3, 2013·JAMA : the Journal of the American Medical Association·Katherine M FlegalBarry I Graubard
Nov 15, 2013·Obesity·Harold E BaysWilliam Canovatchel
Jan 16, 2015·The Journal of Clinical Endocrinology and Metabolism·Caroline M ApovianUNKNOWN Endocrine Society
May 15, 2015·Annual Review of Nutrition·Christian F Rueda-ClausenArya M Sharma
Jul 17, 2015·Diabetes Care·Giulia FerranniniEle Ferrannini
Dec 8, 2015·Obesity Facts·Volkan YumukUNKNOWN Obesity Management Task Force of the European Association for the Study of Obesity
Mar 22, 2016·Expert Opinion on Therapeutic Targets·Panai SongVolker Vallon
Dec 22, 2016·Minerva endocrinologica·Manuel González-OrtizAlejandra M Ramírez-Rodríguez
Sep 19, 2017·The Lancet. Diabetes & Endocrinology·Daniel H Bessesen, Luc F Van Gaal
Oct 14, 2017·Nature Reviews. Endocrinology·Gitanjali Srivastava, Caroline M Apovian
Dec 12, 2017·Journal of Atherosclerosis and Thrombosis·Seigo SugiyamaTomio Jinnouchi
Aug 28, 2018·Experimental and Clinical Endocrinology & Diabetes : Official Journal, German Society of Endocrinology [and] German Diabetes Association·Alejandra M Ramírez-RodríguezEsperanza Martínez-Abundis
Sep 27, 2018·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·P C LeeS-Y Goh
Jan 1, 2019·The Journal of Clinical Endocrinology and Metabolism·Alissa A NewmanChristopher Bell
Jan 23, 2019·Diabetes·Radica Z AlicicKatherine R Tuttle
Feb 1, 2019·Drugs·Maria J Pereira, Jan W Eriksson
Mar 1, 2019·Nature Reviews. Endocrinology·Matthias Blüher
Apr 12, 2019·Obesity Reviews : an Official Journal of the International Association for the Study of Obesity·Emily BrownDaniel J Cuthbertson
Jun 15, 2019·Clinical Kidney Journal·Ander VergaraMaría José Soler
Jul 16, 2020·Nature Reviews. Cardiology·Martin R Cowie, Miles Fisher
Sep 25, 2020·The New England Journal of Medicine·Hiddo J L HeerspinkUNKNOWN DAPA-CKD Trial Committees and Investigators
Oct 31, 2020·Clinical Kidney Journal·Beatriz Fernandez-FernandezAlberto Ortiz
Jan 2, 2021·Current Problems in Cardiology·Rahul GuptaAaqib H Malik

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved